The US Food and Drug Administration (FDA) is considering approval of a first of its kind over-the-counter oral contraceptive pill, submitted by two organisations that are campaigning for its acceptance. But looming changes in policy, coverage and patient protection could provide barriers to its access and use. Continue reading ->
WASHINGTON, DC -- The United States is one of the biggest funders of reproductive health and family planning in multiple developing countries. It is also one of the biggest distributors of contraceptive services in the international market providing all but one: Abortion. The US congressional midterm elections taking place on 6 November could influence further proposed changes to these policies by the current US administration, potentially affecting the lives of millions of women worldwide, for better or worse. Continue reading ->